Ambalal Sarabhai Enterprises Limited (AMBALALSA) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE432A01017
Key metrics
- Market Cap
- ₹337 Cr
- P/E Ratio
- 24.86
- EPS
- 1.77
- Book Value
- 20.67
- P/B Ratio
- 2.13
- ROE
- 11.24%
- ROCE
- 7.57%
- Debt / Equity
- 0.36
- Net Margin
- 8.86%
- Revenue Growth
- 2.91%
- Profit Growth
- 261.05%
- Dividend Yield
- —
- 52W High
- ₹49.98
- 52W Low
- ₹30.15
- Market Cap Band
- micro cap
- Face Value
- 10
Ratios computed from the annual results period ending 2026-03-31.
About Ambalal Sarabhai Enterprises Limited
Ambalal Sarabhai Enterprises Limited, together with its subsidiaries, manufactures and markets pharmaceutical, molecular diagnostics, and electronic products in India and internationally. The company is involved in the supply of pharmaceutical preparations, such as finished dosage forms and active pharmaceutical ingredients; manufacture of fermentation-based pharmaceutical products; and manufacturing and marketing analytical, laboratory, and test and measuring instruments. It also engages in the marketing and distributing professional broadcast, video, and audio equipment; marketing of generic and veterinary formulations; provision of a portfolio of products, including oncology, fertility, women's healthcare, and other specialty therapeutic segments; and manufacturing and marketing of vitamin C coated products. Ambalal Sarabhai Enterprises Limited was incorporated in 1977 and is based in Ahmedabad, India.
- Headquarters
- Ahmedabad, India
- Promoter Holding
- 35.1%
The full Ambalal Sarabhai Enterprises Limited analysis
Create a free account to open the complete AMBALALSA deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.